China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'preoperative pucotenlimab combined with radiotherapy for recurrent resectable retroperitoneal dedifferentiated liposarcoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136298
Registration Time: 2026/11/09
Type: Interventional study
Primary Sponsor: Zhongshan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351918
Published by HT Digital Content Services with permission from Health Daily Digest....